brand logo

Am Fam Physician. 2000;61(10):2972

An item in “Tips from Other Journals,” entitled “Overview of Methods for Treating Allergic Rhinitis” (January 1, 2000, page 207), contained dosage errors in the accompanying table on second-generation antihistamines. The dosage approved by the U.S. Food and Drug Administration for cetirizine is 5 to 10 mg once daily; the approved dosage for loratadine is 10 mg once daily and the approved dosage for loratadine with pseudoephedrine is 10 mg/240 mg once daily. The half-life of claritin was misstated; it is 28 hours. The corrected table is reprinted below.
The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication.

Continue Reading


More in AFP

Copyright © 2000 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.